Efficacy and safty of a quadruple combination of amlodipine, losartan, rosuvastatin, and ezetimibe in ASCVD patients with poor medication adherence (AMOREMIO study)
Event:
ESC Congress 2025
Topic:
Lipid-Lowering Agents
Session:
Refining efficacy and safety of lipid-lowering pharmacotherapy